This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Pasteur Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Devender Satsangi Singh Sandhu: Innovator in Monoclonal Antibody Technology
Introduction
Devender Satsangi Singh Sandhu is a notable inventor based in Thornhill, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions for cancer detection and treatment.
Latest Patents
Devender holds a patent for "Monoclonal antibodies and uses thereof." This technology is crucial for identifying cancer cells. In one embodiment, monoclonal antibodies (mAbs) with specificity for tumor antigens are provided. Additionally, methods for treating cancer using these mAbs are outlined. The patent also includes methods for detecting cancerous cells and kits designed for this purpose.
Career Highlights
Devender is currently employed at Sanofi Pasteur Inc., a leading company in the pharmaceutical industry. His role involves research and development in the field of monoclonal antibodies, contributing to advancements in cancer therapies.
Collaborations
Some of his notable coworkers include Neil L Berinstein and Corey Lovitt. Their collaboration enhances the research efforts in developing effective cancer treatments.
Conclusion
Devender Satsangi Singh Sandhu's work in monoclonal antibody technology represents a significant advancement in cancer detection and treatment. His contributions are vital to the ongoing fight against cancer, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile